Impact Biomedical Overview
- Year Founded
-
2018
- Status
-
Public
- Employees
-
8
- Stock Symbol
-
IBO
- Investments
-
3
- Share Price
-
$6.17
- (As of Tuesday Closing)
Impact Biomedical General Information
Description
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Contact Information
Website
www.impactbiomedinc.comCorporate Office
- 1400 Broadfield Boulevard
- Suite 130
- Houston, TX 77084
- United States
Corporate Office
- 1400 Broadfield Boulevard
- Suite 130
- Houston, TX 77084
- United States
Impact Biomedical Stock Performance
As of 17-Nov-2026, Impact Biomedical’s stock price is $6.17. Its current market cap is $53.3M with 8.64M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.17 | $4.91 | $2.43 - $10.47 | $53.3M | 8.64M | 17.9K | $12.73 |
Impact Biomedical Financials Summary
As of 30-Sep-2026, Impact Biomedical has a trailing 12-month revenue of $38K.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 51,081 | 78,719 | 25,082 | |
| Revenue | 38 | 32 | 0 | 0 |
| EBITDA | 152 | (12,525) | (22,566) | (2,856) |
| Net Income | 1,613 | (11,838) | (24,708) | (4,336) |
| Total Assets | 16,427 | 17,405 | 20,290 | 44,633 |
| Total Debt | 0 | 0 | 8,878 | 12,074 |
Impact Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Impact Biomedical Comparisons
Industry
Financing
Details
Impact Biomedical Competitors (1)
One of Impact Biomedical’s competitors is Applied Biological Laboratories, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Applied Biological Laboratories | Venture Capital-Backed | New York, NY |
Impact Biomedical Signals
Impact Biomedical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Impact Biomedical Acquisitions (3)
Impact Biomedical’s most recent deal was a Reverse Merger with Zoar (Pharmaceuticals). The deal was made on 16-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zoar (Pharmaceuticals) | 16-Sep-2026 | Reverse Merger | Pharmaceuticals | ||
| Document Security Systems (Celios Air Purification) | 25-Feb-2025 | Merger/Acquisition | Electrical Equipment | ||
| Sweet Sense | 08-Nov-2019 | Merger/Acquisition | Food Products |
Impact Biomedical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Impact Biomedical FAQs
-
When was Impact Biomedical founded?
Impact Biomedical was founded in 2018.
-
Where is Impact Biomedical headquartered?
Impact Biomedical is headquartered in Houston, TX.
-
What is the size of Impact Biomedical?
Impact Biomedical has 8 total employees.
-
What industry is Impact Biomedical in?
Impact Biomedical’s primary industry is Drug Discovery.
-
Is Impact Biomedical a private or public company?
Impact Biomedical is a Public company.
-
What is Impact Biomedical’s stock symbol?
The ticker symbol for Impact Biomedical is IBO.
-
What is the current stock price of Impact Biomedical?
As of 17-Nov-2026 the stock price of Impact Biomedical is $6.17.
-
What is the current market cap of Impact Biomedical?
The current market capitalization of Impact Biomedical is $53.3M.
-
What is Impact Biomedical’s current revenue?
The trailing twelve month revenue for Impact Biomedical is $38K.
-
Who are Impact Biomedical’s competitors?
Applied Biological Laboratories is a competitor of Impact Biomedical.
-
What is Impact Biomedical’s annual earnings per share (EPS)?
Impact Biomedical’s EPS for 12 months was $12.73.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process